Sreekanth K. Chaguturu - 01 Apr 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP and Chief Medical Officer
Signature: /s/ Sreekanth K. Chaguturu
Issuer symbol: CVS
Transactions as of: 01 Apr 2024
Net transactions value: +$2,653,326
Form type: 4
Filing time: 03 Apr 2024, 17:03:03 UTC
Previous filing: 28 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock	Tax liability	$117,192	-1,473	-11%	$79.56	12,037	01 Apr 2024	Direct	F1
transaction	CVS	Common Stock	Tax liability	$65,637	-825	-6.9%	$79.56	11,212	01 Apr 2024	Direct	F2
transaction	CVS	Common Stock (Restricted)	Award	$549,998	+6,913	+41%	$79.56	23,666	01 Apr 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Award	$2,286,157	+28,735		$79.56	28,735	01 Apr 2024	Common Stock	28,735	$79.56	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
F2	Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units.
F3	Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025.
F4	Option becomes exercisable in four equal annual installments, commencing 4/1/2025.